BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aicher WK, Korn M, Reitnauer L, Maurer FB, Hennenlotter J, Black PC, Todenhofer T, Bedke J, Stenzl A. Expression patterns of the immune checkpoint ligand CD276 in urothelial carcinoma. BMC Urol 2021;21:60. [PMID: 33845814 DOI: 10.1186/s12894-021-00829-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Harland N, Maurer FB, Abruzzese T, Bock C, Montes-Mojarro IA, Fend F, Aicher WK, Stenzl A, Amend B. Elevated Expression of the Immune Checkpoint Ligand CD276 (B7-H3) in Urothelial Carcinoma Cell Lines Correlates Negatively with the Cell Proliferation. Int J Mol Sci 2022;23:4969. [PMID: 35563359 DOI: 10.3390/ijms23094969] [Reference Citation Analysis]
2 Wei Y, Amend B, Todenhöfer T, Lipke N, Aicher WK, Fend F, Stenzl A, Harland N. Urinary Tract Tumor Organoids Reveal Eminent Differences in Drug Sensitivities When Compared to 2-Dimensional Culture Systems. Int J Mol Sci 2022;23:6305. [PMID: 35682984 DOI: 10.3390/ijms23116305] [Reference Citation Analysis]
3 Zhang Y, Xie Y, Feng Y, Wang Y, Xu X, Zhu S, Xu F, Feng N. Construction and verification of a prognostic risk model based on immunogenomic landscape analysis of bladder caner. Gene 2022;808:145966. [PMID: 34530089 DOI: 10.1016/j.gene.2021.145966] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]